GTS Securities’s Insmed INSM Stock Holding History

GTS Securities’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,200	Closed	-$234K	–	2604
2024 Q3	$234K	Sell	3,200 -60,400	-95%	-$4.46M	﹤0.01%	3526
2024 Q2	$4.26M	Buy	+63,600	New	+$2.47M	0.01%	967

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

GTS Securities's INSM Position: Q2 2026 in Review

GTS Securities sold out of Insmed (INSM) in Q2 2026, closing a stake of 1,991 shares — an estimated $326K sold.

GTS Securities first reported a position in INSM in Q2 2024 and held it in 3 quarters. The position peaked at $326K in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

GTS Securities reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
GTS Securities sold 1,991 Insmed shares in Q2 2026, an estimated $326K.
GTS Securities first reported a position in Insmed in Q2 2024 and held it in 3 quarters.
GTS Securities's Insmed position peaked at $326K in Q1 2026.
667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.